STOCKWATCH
·
Pharmaceuticals
Acquisitions2 Jun 2025, 08:34 pm

Emcure Pharmaceuticals Acquires 26% Stake in Torrent Urja 37 Private Limited for Rs. 3,71,87,740

AI Summary

Emcure Pharmaceuticals Limited has entered into a Share Subscription and Shareholders’ Agreement and Power Transfer Agreement(s) dated June 02, 2025, to acquire at least 26% of the paid-up share capital (on a fully diluted basis) of Torrent Urja 37 Private Limited (TUPL). TUPL is a wholly owned subsidiary of Torrent Green Energy Private Limited and is in the process of setting up a ground mounted solar (photovoltaic) power generation facility with a capacity of 11.27 MWp. This acquisition will help Emcure meet its energy requirements at identified facilities in the state of Gujarat.

Key Highlights

  • Emcure Pharmaceuticals to acquire at least 26% stake in Torrent Urja 37 Private Limited
  • TUPL is a wholly owned subsidiary of Torrent Green Energy Private Limited
  • TUPL is setting up a ground mounted solar power generation facility with a capacity of 11.27 MWp
  • The acquisition will help Emcure meet its energy requirements in Gujarat
  • The cost of acquisition is Rs. 3,71,87,740
EMCURE
Pharmaceuticals
Emcure Pharmaceuticals Ltd

Price Impact